AI assistant
AEHR TEST SYSTEMS — Director's Dealing 2021
Nov 15, 2021
32300_dirs_2021-11-15_050fd46e-ffa5-4c92-b380-93e4339b9fbf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2021-11-11
Reporting Person: Erickson Gayn (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-11 | Common Stock | M | 29880 | $2.1 | Acquired | 472633 | Direct |
| 2021-11-11 | Common Stock | M | 15140 | $1.68 | Acquired | 487773 | Direct |
| 2021-11-11 | Common Stock | M | 10344 | $3.93 | Acquired | 498117 | Direct |
| 2021-11-11 | Common Stock | M | 19003 | $2.4 | Acquired | 517120 | Direct |
| 2021-11-11 | Common Stock | M | 62727 | $1.635 | Acquired | 579847 | Direct |
| 2021-11-11 | Common Stock | S | 80000 | $23.287 | Disposed | 499847 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-11 | Non-Qualified Stock Option (right to buy) | $1.635 | M | 62727 | Disposed | 2026-07-16 | Common Stock (62727) | Direct |
| 2021-11-11 | Non-Qualified Stock Option (right to buy) | $1.68 | M | 15140 | Disposed | 2023-07-25 | Common Stock (15140) | Direct |
| 2021-11-11 | Non-Qualified Stock Option (right to buy) | $2.1 | M | 29880 | Disposed | 2022-04-21 | Common Stock (29880) | Direct |
| 2021-11-11 | Non-Qualified Stock Option (right to buy) | $2.4 | M | 19003 | Disposed | 2025-08-17 | Common Stock (19003) | Direct |
| 2021-11-11 | Non-Qualified Stock Option (right to buy) | $3.93 | M | 10344 | Disposed | 2024-07-11 | Common Stock0 (10344) | Direct |
Footnotes
F1: The shares were sold to cover the exercise cost and income tax payments in connection with the exercise of non-qualified stock options.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.91 to $23.90, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
F3: The amount reported includes shares subject to unvested restricted stock units.
F4: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.